# Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

> **NCT00504023** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Vulvar Cancer

## Interventions

- **DRUG:** imiquimod
- **PROCEDURE:** biopsy
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT00504023
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504023, "Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00504023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*